← All candidates
147 insider filings on record.
147 filings on record.
LMATLEMAITRE VASCULAR INC
NasdaqGM · Healthcare · $1.84B
$80.24
-0.66% · Sep 15
147 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 4 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$1.84B
Float
21.3M
93% public
Short % float
Pro
Price / profit
28.3
Price / future profit
25.2
Price / sales
7.0
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
142 more transactions on Pro →Context
Wall St
$118.75 avg target
+48.0% vs today · 8 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$0.68 act+$0.02
Q4 '25$0.68 act+$0.02
Q3 '25$0.75 act+$0.19
Q2 '25$0.60 act+$0.03
Coverage
How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value TargetsSimply Wall St. · 05-29LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons WhyZacks · 05-251 Reason to Avoid LMAT and 1 Stock to Buy InsteadStockStory · 05-22Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty StocksStockStory · 05-21
The file stays open
147 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice